vs
Side-by-side financial comparison of GERON CORP (GERN) and NETSTREIT Corp. (NTST). Click either name above to swap in a different company.
NETSTREIT Corp. is the larger business by last-quarter revenue ($57.1M vs $47.2M, roughly 1.2× GERON CORP). NETSTREIT Corp. runs the higher net margin — 10.0% vs -39.0%, a 49.0% gap on every dollar of revenue. On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs 24.3%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 20.1%).
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
NETSTREIT Corp. is a US-headquartered real estate investment trust (REIT) that specializes in acquiring and operating a diversified portfolio of single-tenant net lease commercial properties. Its asset portfolio covers retail, industrial and office categories, primarily catering to investment-grade corporate tenants across the United States market.
GERN vs NTST — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $47.2M | $57.1M |
| Net Profit | $-18.4M | $5.7M |
| Gross Margin | — | — |
| Operating Margin | -29.4% | 34.1% |
| Net Margin | -39.0% | 10.0% |
| Revenue YoY | 67.1% | 24.3% |
| Net Profit YoY | 30.3% | 235.9% |
| EPS (diluted) | $-0.03 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $57.1M | ||
| Q4 25 | — | $52.5M | ||
| Q3 25 | $47.2M | $48.3M | ||
| Q2 25 | $49.0M | $48.3M | ||
| Q1 25 | $39.6M | $45.9M | ||
| Q4 24 | — | $44.1M | ||
| Q3 24 | $28.3M | $41.4M | ||
| Q2 24 | $882.0K | $39.6M |
| Q1 26 | — | $5.7M | ||
| Q4 25 | — | $1.3M | ||
| Q3 25 | $-18.4M | $618.0K | ||
| Q2 25 | $-16.4M | $3.3M | ||
| Q1 25 | $-19.8M | $1.7M | ||
| Q4 24 | — | $-5.4M | ||
| Q3 24 | $-26.4M | $-5.3M | ||
| Q2 24 | $-67.4M | $-2.3M |
| Q1 26 | — | 34.1% | ||
| Q4 25 | — | 2.6% | ||
| Q3 25 | -29.4% | 1.3% | ||
| Q2 25 | -25.4% | 6.8% | ||
| Q1 25 | -42.2% | 3.7% | ||
| Q4 24 | — | -12.3% | ||
| Q3 24 | -99.8% | -12.8% | ||
| Q2 24 | -7860.9% | -5.8% |
| Q1 26 | — | 10.0% | ||
| Q4 25 | — | 2.5% | ||
| Q3 25 | -39.0% | 1.3% | ||
| Q2 25 | -33.4% | 6.8% | ||
| Q1 25 | -50.1% | 3.7% | ||
| Q4 24 | — | -12.3% | ||
| Q3 24 | -93.5% | -12.8% | ||
| Q2 24 | -7639.8% | -5.8% |
| Q1 26 | — | $0.32 | ||
| Q4 25 | — | $0.01 | ||
| Q3 25 | $-0.03 | $0.01 | ||
| Q2 25 | $-0.02 | $0.04 | ||
| Q1 25 | $-0.03 | $0.02 | ||
| Q4 24 | — | $-0.07 | ||
| Q3 24 | $-0.04 | $-0.07 | ||
| Q2 24 | $-0.10 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $248.7M | $1.5B |
| Total Assets | $567.4M | $2.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $78.1M | — | ||
| Q2 25 | $77.7M | — | ||
| Q1 25 | $83.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $60.3M | — | ||
| Q2 24 | $116.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $926.6M | ||
| Q1 25 | — | $913.3M | ||
| Q4 24 | — | $868.3M | ||
| Q3 24 | — | $778.7M | ||
| Q2 24 | — | $726.2M |
| Q1 26 | — | $1.5B | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | $248.7M | $1.3B | ||
| Q2 25 | $259.5M | $1.3B | ||
| Q1 25 | $268.2M | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | $292.3M | $1.3B | ||
| Q2 24 | $306.7M | $1.3B |
| Q1 26 | — | $2.8B | ||
| Q4 25 | — | $2.6B | ||
| Q3 25 | $567.4M | $2.5B | ||
| Q2 25 | $555.2M | $2.3B | ||
| Q1 25 | $562.5M | $2.3B | ||
| Q4 24 | — | $2.3B | ||
| Q3 24 | $444.9M | $2.2B | ||
| Q2 24 | $449.4M | $2.1B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.84× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.70× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.58× | ||
| Q2 24 | — | 0.55× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-13.6M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $109.5M | ||
| Q3 25 | $-13.6M | $28.0M | ||
| Q2 25 | $-27.4M | $30.6M | ||
| Q1 25 | $-48.0M | $22.1M | ||
| Q4 24 | — | $90.2M | ||
| Q3 24 | $-58.9M | $25.1M | ||
| Q2 24 | $-53.5M | $25.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-53.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -6086.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 23.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 82.46× | ||
| Q3 25 | — | 45.27× | ||
| Q2 25 | — | 9.36× | ||
| Q1 25 | — | 13.06× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GERN
Segment breakdown not available.
NTST
| Rental revenue (including reimbursable) | $54.0M | 95% |
| Other | $3.0M | 5% |